Dr. Freya Jan Silverstein, MD

Dr. Silverstein practices at HCA Florida JFK Hospital in Atlantis, Florida, part of HCA Healthcare.

Dr. Silverstein's NPI, 1669467460, was assigned on September 18, 2005. Dr. Silverstein graduated from SUNY Downstate Health Sciences University in 1983. Dr. Silverstein holds Florida license ME0046801.

Dr. Silverstein's primary practice is HCA Florida JFK Hospital, at 5301 S Congress Ave, Atlantis, FL 33462 in Palm Beach County. The practice phone is (561) 965-7300.

Dr. Silverstein's primary practice is HCA Florida JFK Hospital in Atlantis, Florida, part of HCA Healthcare. Dr. Silverstein is also affiliated with Bethesda Hospital East. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Silverstein to 3 more hospitals, 3 dialysis centers, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silverstein practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Silverstein's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Silverstein is board certified in internal medicine by the American Board of Internal Medicine. Dr. Silverstein is licensed in Florida.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, kidney disease and parathyroid gland disorder among the conditions Dr. Silverstein treats.

CMS data shows 4,476 Medicare services from Dr. Silverstein across 17 procedure codes in 2024, for 745 Medicare patients. Medicare paid $371,058 for them.

CMS counts 745 Medicare patients who saw Dr. Silverstein in 2024. The largest group is 75 to 84, with 313 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silverstein's median patient age at 75, with 48% women.

In 2024, Dr. Silverstein wrote 2,921 Medicare Part D claims for 460 patients. 78% of them were for generic drugs. CMS names the drug for 2,488 of them, across 59 drugs with 11 or more claims each, at $808,065 in total drug cost. In 2023, CMS named 2,227 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Silverstein for performance year 2024, reported individually. Dr. Silverstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silverstein as offering telehealth.

CMS Open Payments shows 176 general payments to Dr. Silverstein from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $637.

Dmand AI lists 3 awards for Dr. Silverstein, most recently CMS Stage 1 2012 in 2011.

Dr. Silverstein graduated from SUNY Downstate Health Sciences University in 1983. Dr. Silverstein is a member of ACP.

Dr. Silverstein is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.